← Evidence map

ReviewChronic diseases and translational medicine2022

The earlier, the better? A review of neoadjuvant immunotherapy in resectable non-small-cell lung cancer.

Fajiu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35774424